National Quality Measures Clearinghouse | Measures by Topic: Mental Disorders 7

National Quality Measures Clearinghouse | Measures by Topic

Measures by Topic

Disease/Condition > Psychiatry and Psychology (333) >

Mental Disorders (217)

Narrow:

Adjustment Disorders (1)
Anxiety Disorders (8)
Delirium, Dementia, Amnestic, Cognitive Disorders (9)

View all...

121-140 of 217   < Previous | Next >
121. Antidepressant medication management (effective continuation phase treatment): percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression and treated with antidepressant medication and who remained on an antidepressant medication for at least 180 days (6 months). 2012 Jan. [NQMC Update Pending] NQMC:008913 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
122. Engagement of alcohol and other drug (AOD) treatment: percentage of patients who initiated treatment and who had two or more additional services with a diagnosis of AOD within 30 days of the initiation visit. 2012 Jan. [NQMC Update Pending] NQMC:008929 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
123. Follow-up care for children prescribed ADHD medication (continuation and maintenance [C&M] phase): percentage of patients 6 to 12 years of age as of the Index Prescription Start Date with an outpatient ADHD medication who remained on the medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended. 2012 Jan. [NQMC Update Pending] NQMC:008915 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
124. Follow-up care for children prescribed ADHD medication (initiation phase): percentage of patients 6 to 12 years of age as of the Index Prescription Start Date with an outpatient ADHD medication who had one follow-up visit with a practitioner with prescribing authority during the 30-day Initiation Phase. 2012 Jan.[NQMC Update Pending] NQMC:008914 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
125. Initiation of alcohol and other drug (AOD) treatment: percentage of patients who initiate treatment through an inpatient AOD admission, outpatient visit, intensive outpatient service or partial hospitalization within 14 days of the diagnosis. 2012 Jan. [NQMC Update Pending] NQMC:008928 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
126. Sedation and analgesia: percentage of mechanical ventilation (MV) patients with cognitive deterioration administered analgesics. 2011 Mar. NQMC:008502 Spanish Society of Intensive and Critical Care and Units Coronary - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
127. Sedation and analgesia: percentage of mechanically ventilated patients evaluated for the presence of delirium. 2011 Mar. NQMC:008505 Spanish Society of Intensive and Critical Care and Units Coronary - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
128. Carpal tunnel syndrome (CTS): percentage of eligible patients who are off work for four or more weeks for CTS-related symptoms for whom the visit note documented the presence or absence of one or more of the following: 1) alcohol or substance abuse, 2) depression or anxiety, or 3) other barriers to return to work. 2011 Jan. NQMC:008392 RAND Corporation - Nonprofit Research Organization. View all measures by the developer(s) Compare Selected
129. Chronic stable coronary artery disease: percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who were screened for tobacco use AND who received tobacco cessation counseling intervention if identified as a tobacco user. 2011 Jan. NQMC:007239 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
130. Child and adolescent major depressive disorder: percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with a plan for follow-up care documented. 2010 Sep. NQMC:004441 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
131. Child and adolescent major depressive disorder: percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with an assessment for suicide risk. 2010 Sep. NQMC:004438 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
132. Child and adolescent major depressive disorder: percentage of patients aged 6 through 17 years with a diagnosis of major depressive disorder for whom an antidepressant medication was considered or prescribed during an episode of major depressive disorder. 2010 Sep. NQMC:004440 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
133. Child and adolescent major depressive disorder: percentage of patients aged 6 through 17 years with a diagnosis of major depressive disorder who received or were referred for psychotherapy during an episode of major depressive disorder. 2010 Sep. NQMC:004439 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
134. Child and adolescent major depressive disorder: percentage of patients aged 6 through 17 years with a diagnosis of major depressive disorder who were interviewed directly by the evaluating clinician on or before the date of diagnosis. 2010 Sep. NQMC:004436 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
135. Child and adolescent major depressive disorder: percentage of patients aged 6 through 17 years with a diagnosis of major depressive disorder with documented evidence that they met the DSM-IV criteria [at least 5 elements with symptom duration of two weeks or longer, including 1) depressed mood (can be irritable mood in children and adolescents) or 2) loss of interest or pleasure] during the visit in which the new diagnosis or recurrent episode was identified. 2010 Sep. NQMC:004437 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
136. Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD who had a suicide risk assessment completed at each visit during the measurement period. 2010 Sep. NQMC:004017 Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by thedeveloper(s) Compare Selected
137. Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD who receive therapy appropriate to their classification during the measurement period. 2010 Sep. NQMC:004019 American Psychiatric Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
138. Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD who were initially treated with antidepressant medication who had the antidepressant medication discontinued who were continued on antidepressant medication for a minimum of 16 weeks following remission of symptoms during the measurement period. 2010 Sep. NQMC:004020 American Psychiatric Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
139. Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD whose severity of depressive disorder was assessed during the visit in which the new diagnosis or recurrent episode was identified during the measurement period. 2010 Sep. NQMC:004018 American Psychiatric Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
140. Major depressive disorder (MDD): percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD, who met the DSM-IV criteria during the visit in which the new diagnosis or recurrent episode was identified. 2010 Sep. NQMC:004016 American Psychiatric Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
121-140 of 217   < Previous | Next >